J.J. Lafitte

2.1k total citations
43 papers, 1.5k citations indexed

About

J.J. Lafitte is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, J.J. Lafitte has authored 43 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 20 papers in Oncology and 15 papers in Molecular Biology. Recurrent topics in J.J. Lafitte's work include Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Research Studies (16 papers) and Lung Cancer Diagnosis and Treatment (9 papers). J.J. Lafitte is often cited by papers focused on Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Research Studies (16 papers) and Lung Cancer Diagnosis and Treatment (9 papers). J.J. Lafitte collaborates with scholars based in France, Belgium and Greece. J.J. Lafitte's co-authors include Marianne Paesmans, Thierry Berghmans, Céline Mascaux, Jean‐Paul Sculier, Anne‐Pascale Meert, Pascal Roussel, J.P. Sculier, Michel Lhermitte, G Lamblin and A.-P. Meert and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

J.J. Lafitte

41 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.J. Lafitte France 22 748 601 444 270 109 43 1.5k
Yoichi Nakamura Japan 21 553 0.7× 936 1.6× 610 1.4× 112 0.4× 89 0.8× 92 1.6k
Jean‐Pierre Bergerat France 25 615 0.8× 699 1.2× 702 1.6× 572 2.1× 74 0.7× 80 2.5k
Luis López Lázaro Spain 25 419 0.6× 401 0.7× 430 1.0× 121 0.4× 41 0.4× 63 1.6k
Lorraine Pelosof United States 16 299 0.4× 694 1.2× 371 0.8× 300 1.1× 78 0.7× 35 1.8k
Yasuaki Nakajima Japan 23 693 0.9× 416 0.7× 472 1.1× 288 1.1× 54 0.5× 123 2.0k
In‐Jae Oh South Korea 27 1.5k 2.0× 1.1k 1.8× 568 1.3× 304 1.1× 145 1.3× 211 2.6k
Louis WC Chow China 27 292 0.4× 791 1.3× 538 1.2× 119 0.4× 47 0.4× 78 1.8k
Emma Bateman Australia 18 823 1.1× 618 1.0× 320 0.7× 73 0.3× 99 0.9× 37 1.4k
Moritoshi Kinoshita Japan 28 200 0.3× 538 0.9× 1.0k 2.3× 498 1.8× 148 1.4× 75 2.3k

Countries citing papers authored by J.J. Lafitte

Since Specialization
Citations

This map shows the geographic impact of J.J. Lafitte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.J. Lafitte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.J. Lafitte more than expected).

Fields of papers citing papers by J.J. Lafitte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.J. Lafitte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.J. Lafitte. The network helps show where J.J. Lafitte may publish in the future.

Co-authorship network of co-authors of J.J. Lafitte

This figure shows the co-authorship network connecting the top 25 collaborators of J.J. Lafitte. A scholar is included among the top collaborators of J.J. Lafitte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.J. Lafitte. J.J. Lafitte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Westeel, Virginie, Fabrice Barlési, J.J. Lafitte, et al.. (2017). Results of the phase III IFCT-0302 trial assessing minimal versus CT-scan-based follow-up for completely resected non-small cell lung cancer (NSCLC). Annals of Oncology. 28. v452–v452. 25 indexed citations
2.
Jungels, Christiane, T. Berghmans, A.-P. Meert, et al.. (2011). Traitement de rattrapage par pémétrexed pour les CBNPC : étude rétrospective d’implémentation. Revue des Maladies Respiratoires. 29(1). 21–27. 4 indexed citations
3.
Paesmans, Marianne, J.J. Lafitte, J. Lecomte, et al.. (2011). Validation and comparison of several published prognostic systems for patients with small cell lung cancer. European Respiratory Journal. 38(3). 657–663. 6 indexed citations
4.
Scherpereel, Arnaud, Thierry Berghmans, J.J. Lafitte, et al.. (2010). Valproate–doxorubicin: promising therapy for progressing mesothelioma. A phase II study. European Respiratory Journal. 37(1). 129–135. 72 indexed citations
5.
Sculier, Jean‐Paul, J.J. Lafitte, Anna Efremidis, et al.. (2008). A phase III randomised study of concomitant induction radiochemotherapy testing two modalities of radiosensitisation by cisplatin (standard versus daily) for limited small-cell lung cancer. Annals of Oncology. 19(10). 1691–1697. 21 indexed citations
6.
Berghmans, T., J.J. Lafitte, J. Lecomte, et al.. (2007). Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party. British Journal of Cancer. 96(11). 1644–1649. 10 indexed citations
7.
Makris, Demosthènes, et al.. (2007). Haemothorax after pig-tail catheter removal in a patient with primary spontaneous pneumothorax. Emergency Medicine Journal. 24(3). e17–e17. 2 indexed citations
8.
Berghmans, Thierry, J.J. Lafitte, J Thiriaux, et al.. (2004). Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy. Lung Cancer. 45(3). 339–348. 19 indexed citations
9.
Berghmans, T., A.-P. Meert, Céline Mascaux, et al.. (2003). Citation indexes do not reflect methodological quality in lung cancer randomised trials. Annals of Oncology. 14(5). 715–721. 32 indexed citations
10.
Sculier, Jean‐Paul, Thierry Berghmans, J.J. Lafitte, et al.. (2002). A phase II study testing paclitaxel as second-line single agent treatment for patients with advanced non-small cell lung cancer failing after a first-line chemotherapy. Lung Cancer. 37(1). 73–77. 21 indexed citations
11.
Cauffiez, Christelle, Delphine Allorge, Jean‐Marc Lo‐Guidice, et al.. (2001). Five novel natural allelic variants?951A>C, 1042G>A (D348N), 1156A>T (I386F), 1217G>A (C406Y) and 1291C>T (C431Y)?of the human CYP1A2 gene in a French Caucasian population. Human Mutation. 17(4). 355–356. 55 indexed citations
12.
Miotto, Deborah, Pota Christodoulopoulos, Ron Olivenstein, et al.. (2001). Expression of IFN-γ–inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases. Journal of Allergy and Clinical Immunology. 107(4). 664–670. 125 indexed citations
13.
Mascaux, Céline, Marianne Paesmans, Thierry Berghmans, et al.. (2000). A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis. Lung Cancer. 30(1). 23–36. 179 indexed citations
14.
Sculier, J.P., J.J. Lafitte, T. Berghmans, et al.. (2000). A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancer. Lung Cancer. 29(1). 67–73. 41 indexed citations
15.
16.
Sculier, J.P., Marianne Paesmans, J Thiriaux, et al.. (1999). A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer. European Journal of Cancer. 35(9). 1314–1319. 20 indexed citations
17.
Sculier, Jean‐Paul, Marianne Paesmans, Vincent Ninane, et al.. (1998). Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy. Lung Cancer. 22(3). 201–213. 11 indexed citations
18.
Marez, Delphine, José Cosme, N. Sabbagh, et al.. (1998). Cytochrome P450 CYP2D6 gene polymorphism and lung cancer susceptibility in Caucasians. Pharmacogenetics. 8(1). 7–14. 16 indexed citations
19.
Roux, Nicolas, Bernard Cortet, J.J. Lafitte, et al.. (1996). Pneumocystis carinii pneumonia in rheumatoid arthritis patients treated with methotrexate. A report of two cases.. PubMed. 63(6). 453–6. 19 indexed citations
20.
Périni, Jean‐Marc, et al.. (1989). Use of an antiserum against deglycosylated human mucins for cellular localization of their peptide precursors: antigenic similarities between bronchial and intestinal mucins.. Journal of Histochemistry & Cytochemistry. 37(6). 869–875. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoichi Nakamura Breakdown of academic impact, for papers by Jean‐Pierre Bergerat Breakdown of academic impact, for papers by Luis López Lázaro Breakdown of academic impact, for papers by Lorraine Pelosof Breakdown of academic impact, for papers by Yasuaki Nakajima Breakdown of academic impact, for papers by In‐Jae Oh Breakdown of academic impact, for papers by Louis WC Chow Breakdown of academic impact, for papers by Emma Bateman Breakdown of academic impact, for papers by Moritoshi Kinoshita
Rankless by CCL
2026